Pancreatic Cancer Research

ResearcherLaboratoire de physiologie cellulaire et moléculaireActive in the last 2 years

Halima Ouadid‐Ahidouch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-8266-5631; OpenAlex author ID A5021804326. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
  2. Acid Adaptation Promotes TRPC1 Plasma Membrane Localization Leading to Pancreatic Ductal Adenocarcinoma Cell Proliferation and Migration through Ca2+ Entry and… Last author DOI 10.3390/cancers14194946↗
  3. The TRPC1 Channel Forms a PI3K/CaM Complex and Regulates Pancreatic Ductal Adenocarcinoma Cell Proliferation in a Ca2+-Independent Manner. Last author DOI 10.3390/ijms23147923↗
  4. TRPM7/RPSA Complex Regulates Pancreatic Cancer Cell Migration. Co-author DOI 10.3389/fcell.2020.00549↗
  5. Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fphar.2020.568993↗
  6. The Transient Receptor Potential Melastatin 7 Channel Regulates Pancreatic Cancer Cell Invasion through the Hsp90α/uPA/MMP2 pathway. Co-author DOI 10.1016/j.neo.2017.01.004↗
  7. Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cel… Last author DOI 10.1002/ijc.27487↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Julie Schnipper · 4 shared papers, 2020–2026 · strength 0.65
  2. Stine F. Pedersen · 3 shared papers, 2022–2026 · strength 0.49
  3. Pierre Rybarczyk · 4 shared papers, 2012–2022 · strength 0.35
  4. Mathieu Gautier · 3 shared papers, 2012–2020 · strength 0.21
  5. Pawel Swietach · 1 shared paper, 2026 · strength 0.19
  6. Sofie Hagelund · 1 shared paper, 2026 · strength 0.19
  7. Verena Hofschröer · 1 shared paper, 2026 · strength 0.19
  8. Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
  9. Zoltán Pethő · 1 shared paper, 2026 · strength 0.19
  10. Tiago M. A. Carvalho · 1 shared paper, 2026 · strength 0.19
  11. Stephan J. Reshkin · 1 shared paper, 2026 · strength 0.19
  12. Torsten Hechler · 1 shared paper, 2026 · strength 0.19
  13. Rosa Angela Cardone · 1 shared paper, 2026 · strength 0.19
  14. Wiktoria Błaszczak · 1 shared paper, 2026 · strength 0.19
  15. Frauke Alves · 1 shared paper, 2026 · strength 0.19
  16. Ganga Deshar · 1 shared paper, 2026 · strength 0.19
  17. Ivana Novak · 1 shared paper, 2026 · strength 0.19
  18. Albrecht Schwab · 1 shared paper, 2026 · strength 0.19
  19. Renata Ialchina · 1 shared paper, 2026 · strength 0.19
  20. Natalia B. Prevarskaya · 1 shared paper, 2026 · strength 0.19
  21. Madelaine Magalì Audero · 1 shared paper, 2026 · strength 0.19
  22. Luis A. Pardo · 1 shared paper, 2026 · strength 0.19
  23. Roisin McMorrow · 1 shared paper, 2026 · strength 0.19
  24. Alessandra Fiorio Pla · 1 shared paper, 2026 · strength 0.19
  25. Anna Trauzold · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.